2 Huntington’s disease Parkinson’s disease Amylotrophic lateral sclerosis Alzheimer’s Disease Neurodegenerative Disorders.

Slides:



Advertisements
Similar presentations
Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which? Lockhart BP, Lestage PJ. January 2003.
Advertisements

Alzheimer’s Disease Stephen S. Flitman, MD Medical Director 21 st Century Neurology a division of Xenoscience, Inc. Phoenix, Arizona.
Alzheimer Disease. The year 2006 is the centenary of the famous presentation of Alois Alzheimer which first described the neuropathology of Alzheimer’s.
Etiopathogenesis of Alzheimer's disease
This is only for personal educational purposes.
ALZHEIMER'S DISEASE (AD)
MCB 135K: Discussion March 2, General Info Mid-Term I: –Avg 87 –Std. Deviation 10 –Re-grades by next Wednesday Include a cover sheet that addresses.
Aging of the Nervous System: Structural Changes Chapters 7, 8, 9 PS Timiras Chapters 7, 8, 9 PS Timiras.
Alzheimer’s Disease Nicotine’s relationship and contribution to dementia.
Alzheimer’s Disease Find group of ~4 students ~ 10 minutes Discuss the following personal family connection to AD (if willing only) observations/experiences.
Pathology and Treatment
What is Aging? Alzheimer’s Disease Parkinson’s Disease.
Alzheimer’s Disease By: Ryan Triplett. Alzheimer’s The deterioration of intellectual capabilities, memory, judgment, and personality to the extent that.
The Brain. Problems with the Brain… Dementia – group of symptoms affecting intellectual and social abilities severely enough to interfere with daily.
AGING AND TRAUMA Key Points Increased longevity results in increased neurological disorders ‘Normal’ age-related changes in brain structure Neurodegenerative.
Cognitive Enhancers. Dementia A syndrome due to disease of the brain, characterised by progressive, global deterioration in intellect including: Memory.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 22 Alzheimer’s Disease.
ALZHEIMER’S DISEASE BY OLUFOLAKUNMI KEHINDE PRE-MD 1.
Alzheimer’s Disease Angela Singh, PharmD Associate Professor of Pharmacy Practice Florida A&M University College of Pharmacy & Pharmaceutical Sciences.
ALZHEIMER’S PART 2. AD VIDEO
Definition of Dementia n An acquired complex of intellectual deterioration which affects at least two areas of cognitive function. n A syndrome, not a.
Biological Myths of Aging Memory declines drastically with age for all people. IQ declines drastically with age in all people. Learning becomes more difficult.
Alzheimer’s Disease Landscape
Progress Report on Alzheimer’s Disease Taking the Next Steps NIA NIH.
Alzheimer’s Disease Causes, Effects, and Treatments.
Amnesia Syndromes Lesson 22. Wernicke-Korsakoff’s Syndrome n Deficits similar to H.M. l Anterograde l retrograde more severe n Cause: Long-term alcohol.
Alzheimer Disease By Ashley Wallace. Facts Discovered by Alois Alzheimer in 1907Discovered by Alois Alzheimer in /3 or more of all diagnosed cases.
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease associated with brain shrinkage and the loss of neurons, particularly cholinergic.
Alzheimer’s Disease -> The Disease of Darkness Varun Doshi.
Alzheimer’s Disease By: Chelcy Branon. Facts  In 2006, there were 26.6 million sufferers worldwide  Costs 100 billion dollars per year.
Medical University of Sofia, Faculty of Medicine Department of Pharmacology and Toxicology Alzheimer’s Disease Avi Gandhi (2009)
Heather Kellogg March 6, 2013 Honors Psychology, Period 1
COLUMBIA PRESBYTARIAN HOSPITAL CENTER
1 Alzheimer’s Disease & Acetylcholine Presentation by: Huy Nguyen Chemistry 12B Instructor: Dr. Adamczeski Fall-2006.
Dr. Usman Ghani CNS Block.  Pathophysiology of alzheimer’s disease: 5I.
Aging Nervous System. Neurotrophic Factors Necessary for Maintenance of Neurons Neurotrophin function o Play role in development of NS o Interact with.
ALZHEIMER’S DISEASE Sania Munir Medical Biotechnology (BIOT 412)
Progressive, degenerative disorder Attacks the brain's neurons Results in loss of memory, thinking and language skills, and behavioral changes Confusion.
Dementia. What is Dementia? Dementia is a gradual decline of mental ability that affects your intellectual and social skills to the point where daily.
ALZHIEMERS DISEASE IN UK ‘’The Dementia Time bomb’’ By VISHAL ZAVERI AND ORE AJAI.
Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU.
A Lifetime of Quality Care That’s Convenient & Complete Alzheimer’s Disease Robert Grimshaw, MD FACP A Lifetime of Quality Care That’s Convenient & Complete.
Protection of rat primary hippocampal cultures from Aβ cytotoxicity by pro-inflammatory molecules is mediated by astrocytes Neurobiology of disease, Vol.
National Institute on Aging
Assessment and Diagnosis of Dementia Dr Alison Haddow.
Alzheimer’s Disease Gavin Mast, Musa Abdus-Samad, Arash Rezaeian, Sarah Rocha PHM142 Fall 2015 Instructor: Dr. Jeffrey Henderson.
Epidemiology of Alzheimer’s Disease
ALZHEIMER’S WHAT IS IT – WHAT TO DO ABOUT IT. VIDEO
Amyotrophic lateral sclerosis
Dementia Care Wendy Burnett CNS for Older People.
Under the supervision of miklós jászberényi
Alzheimer's disease M O Jamali, H Saeed & T Mathew.
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
Alzheimer's By Emily Toro Period 1.
Alzheimer’s Disease (AD)
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
Alzheimer’s Disease and Cholesterol
Alzheimer’s Disease (AD)
Aging in the CNS.
Neurocognitive Disorders
Alzheimer’s Disease Dr. Usman Ghani CNS Block.
Alzheimer’s Disease CNS Block.
Alzheimer’s Disease Medical University of Sofia, Faculty of Medicine
Amnesia Syndromes Lecture 21.
Dementia Supischa Theerasasawat Eric Pfeiffer, M.D J. Wesson Ashford
Progress Report on Alzheimer’s Disease
Drugs for Degenerative Diseases of the Nervous System
PowerPoint made by: Monique Johnson
Alzheimer’s Disease Dr. Usman Ghani Neuropsychiatry Block.
Presentation transcript:

2 Huntington’s disease Parkinson’s disease Amylotrophic lateral sclerosis Alzheimer’s Disease Neurodegenerative Disorders

Degenerative brain disorder developed in adulthood (brain cells die) Progressive and irreversible decline in memory and other cognitive abilities ~4.5 million people in America Some Facts

Forgetfulness and loss of smell Memory loss becomes more severe Language, perceptual, and motor skills deteriorate Mood becomes unstable Lost of mobility and control of body functions Death Symptoms

Diagnosis by exclusion –Medical history and mental status exams –Physical examination –Neurological exam –Blood count –CT, PET, and MRI scans to detect brain volume and activity Confirmed by autopsy Tau and β-amyloid test? Other developed tests have been unsuccessful Diagnosis

Genetics –Apolipoprotein E4 (APOE4) –Deletions in gene coding for α-macroglobulin (serum protease inhibitor) –LDL gene? Type II Diabetes Down Syndrome High cholesterol levels Stroke and previous head injuries Tobacco High homocysteine concentration in blood Risk Factors

Familial Alzheimer’s Disease –Caused by a genetic mutation –All are early onset (younger than 60 years) –Accounts for 10% of the cases Sporadic Alzheimer’s Disease –Most common (90% of the cases) –Typically occurs after age 65 Types

Older patients of Down’s syndrome also have neurofirillary tangles and senile plaques Martin, Joseph, N Engl J Med 1 1 Familial Autosomal AD

Amyloid hypothesis –β-amyloid protein tau hypothesis –tau protein Hypotheses

Appear first in the cerebral cortex Results from improper cleavage of APP Made by β-amyloid, tau, ubiquitin, α- antichymotrypsin, apolipoprotein E, presenilins 1 and 2, α-macroglobulin β-amyloid fragment (39 – 43 a.a.) is “sticky” and aggregates Forms intracellularly and transported outside of the neuron Senile Plaques

Activates de immune system Disrupts neuron communication and inflammation β-amyloid facilitates Ca +2 entry to neurons Mitogen-Activated Protein Kinase (MAPK) Inhibits ubiquitin degradation Insufficient to cause cell death High metal concentration Senile Plaques APP Copper binding domain

Senile Plaques

Senile Plaques

Senile Plaques

Martin, Joseph, N Engl J Med known mutations Senile Plaques

Amyloid Tracer “Compound B” highlights β-amyloid Currently under human trials Developed at the University of Pittsburgh Sweden's Uppsala University University of Pittsburgh Medical Center

PIB Proc Natl Acad Sci U S A October 14; 100(21): 12462–12467.

Presenilin 1 mutations Presenilin 2 mutations Martin, Joseph, N Engl J Med Presenilin

Astrocytes become more numerous and produce prostaglandin mediated inflammation Microglial cells produce free radicals –Produce InterLeukin-1β (IL-1β) and Tumor Necrosis-α (TNF-α) (inflammatory cytokines) –Induce enzymes like nitric oxide synthetase Inflammation damages neurons causing neuron death Astrocytes and Microglia Cells

Typically begin in the entorhinal cortex Visualized as paired helical filaments on electron microscopy tau protein maintains the structural integrity of microtubules within neurons In AD, tau protein becomes hyperphosporylated Hyperphosporylated tau binds to each other forming NFTs Neurons full of NFTs die Neurofibrillary Tangles

NFTs not present in all cases NFTs kill output neurons mostly: –Cholinergic neurons (Ach) –Large pyramidal neurons –Output neurons in the hippocampus Neurofibrillary Tangles

Protein portion of lipoproteins (LDL, HDL, etc.) that transport cholesterol Synthesized in the liver, by the brain astrocytes, and oligodendrocytes Does not cross the Blood Brain Barrier Important risk factor Apolipoprotein

299aa glycoprotein Acts as the binding site for LDL receptors –Allows lipids to get into the cell Major lipoprotein for lipid transport between neurons –cholesterol used for synapse plasticity and repair of damaged neurons Removes oxidized lipids from the brain Three common forms (E2, E3, and E4) Usually secreted after brain damage Apolipoprotein E

High insulin concentration stimulates nitric oxide synthetase –Combines nitric oxide with superoxide to produce peroxynitrite –Peroxynitrite causes Tyr nitration AD patients show high Tyr nitration in both neurons and glial cells Insulin

Nicotine in rats produces elevation of Nerve Growth Factor, enhancing Acetylcholine production and release Nicotine reduces β-amyloid production Incidence of AD is more than double for smokers compared to non-smokers Tobacco

Acetylcholinesterase inhibitors NMDA Receptor Antagonists –Memantine (Namenda) β-secretase (BACE) inhibitor? Anti-amyloid vaccine? Detoxification of β-amyloid? Metal ions reduction (Clioquinol)? Vitamin E intake Treatments

Regulate attention, the first stage of learning, and memory Use acetylcholine as a neurotransmitter Have more microtubules than other neurons Cholinergic Neurons

Breaks acetylcholine Promotes aggregation of β-amyloid Acetylcholineste rase + +H 2 O

Donepezil (Aricept) Galantamine (Reminyl) Rivastigmine (Exelon) Tacrine (Cognex) Acetylcholine AchE Inhibitors

Memantine/Auxura/Namenda Regulates Calcium influx Replaces Magnesium Ions NMDA Receptor Antagonist

Chelates copper and zinc in vitro Treatment reversed the deposition of amyloid in the brains of mice with AD Clioquinol cut amyloid deposits in half over a nine week period with no adverse effects. Clioquinol